To determine the indicators of severe bleeding in children with severe dengue viral infection (DVI), the medical records of patients aged <15 years admitted to Songklanagarind Hospital in southern Thailand during 1989-2011 were reviewed. Severe-bleeding DVI was defined as needing blood products transfusion owing to DVI-caused bleeding. Of the 238 children with severe DVI according to the World Health Organization 2009 criteria, 44 (18.5%) had severe bleeding, of whom 28 (63.6%) died. The international normalized ratio (INR) had high correlations with both transaminase enzymes (Spearman correlation, r s ¼ 0.67-0.69, p <0.01). Multivariate analysis found that patients who had dengue haemorrhagic fever (DHF) grade IV, platelets <20 000/mm 3 and INR ! 1.5 had increased risk of severe bleeding with odds ratios (95% confidence intervals) of 3.4 (1.4, 8.6), 2.6 (1.1, 6.2) and 10.6 (4.0, 28.4), respectively. Blood products should be at hand in severe DHF children with high risk of severe bleeding.
I N T R O D U C T I O N
More than 50 million cases of dengue fever and several hundred thousand cases of dengue haemorrhagic fever (DHF), with an overall fatality rate of approximately 0.2-2%, occur each year in tropical countries [1] . Dengue shock syndrome (DSS) with multiorgan failure and massive bleeding is the major cause of death in patients who have dengue viral infection (DVI) [2] [3] [4] [5] [6] [7] [8] [9] .
The immunopathogenesis of DVI-related bleeding disorders is poorly understood. Various studies have suggested that endothelium injury leading to consumptive thrombocytopenia and coagulopathy, increased fibrinolysis and acute liver injury causing coagulopathy and disseminated intravascular coagulation (DIC) might play a major role in hemorrhage in DVI [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
Mild bleeding disorders such as petechiae are common in DHF and are mainly caused by thrombocytopenia and/or vasculopathy [22] [23] [24] [25] . In a minority of patients with massive DVI-related bleeding, coagulation abnormalities are commonly found. A study in adult patients with DHF found that of 10 patients who died, 6 had active upper gastrointestinal (GI) tract bleeding, and all of these 6 patients had prothrombin time (PT) prolongation and 2 of 6 had platelets <20 000/mm 3 [6] . A retrospective study in adult patients with DVI found that female gender, thrombocytopenia and absolute lymphocyte counts >500 cells/mm 3 were indicators of high risk for developing clinically significant bleeding (GI bleeding, hematuria and menorrhagia) [26] .
To our knowledge, no study has explored the risk factors of severe bleeding in children with severe DVI. Awareness of these risk factors could help guide treatment of patients at increased risk for bleeding and ensure blood products are available in such cases for prompt treatment because prompt and effective control of severe bleeding is essential for a favorable outcome in such cases.
A previous retrospective study from our institution found that children with severe DVI who had acute respiratory failure (ARF) and/or severe bleeding were at risk of lethal DHF/DSS [27] . In this current study, we wanted to examine the risk factors and clinical outcomes of severe DVI patients who had severe bleeding using the same retrospective cohort as in our previous study.
M E T H O D S
We retrospectively reviewed the medical records of all children (<15 years of age) diagnosed with severe DVI admitted from January 1989 to December 2011 in Songklanagarind Hospital, Thailand. Permission from the institutional review board of Prince of Songkla University was obtained before conducting the study.
DHF was diagnosed according to the criteria of the World Health Organization (WHO). Demographic characteristics and known potential risk factors for disease severity were recorded, including age, sex, underlying diseases, weight standard deviation score (WSDS), obesity (WSDS >2) and severity of DVI according to WHO criteria [1] . To determine the risk factors of severe bleeding, the hemostatic factors [lowest platelet count, highest international normalized ratio (INR), PT and activated partial thromboplastin times (aPTT)] and liver function tests (LFTs), including highest levels of direct bilirubin (DB), total bilirubin (TB), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and the lowest level of albumin, were obtained from the medical records.
Patients who had DSS, organ failure or impaired consciousness (including seizure) or AST >1000 U/l were classified as severe DVI [1] . Respiratory failure was defined as severe hypoxemia requiring a mechanical ventilator. Acute kidney injury (AKI) was defined as a sudden increase in serum creatinine (Cr) levels >2 mg/dl or a serum Cr concentration >2 times previous or subsequent values and that was also higher than the upper limit of normal values for the patient's age [28] . Acute liver failure (ALF) was defined as the rapid development of severe acute liver injury with impaired synthetic function (INR !1.5 or PT >15 s) and encephalopathy or INR ! 2.0 or PT > 20 s irrespective of hepatic encephalopathy in patients with no history of liver disease [29] . Severe bleeding was defined as bleeding requiring packed red cells and/or other blood components to control. Significant organ bleeding was defined as gross bleeding from the GI, respiratory, urinary or reproductive (hypermenorrhea) tracts.
S T A T I S T I C A L A N A L Y S I S
Data were evaluated using descriptive statistics [mean and standard deviation, median and interquartile range (IQR) or frequency and percentage, as appropriate]. Comparisons between severe DVI patients who died and survived were made using Student's t-test or Mann-Whitney U-test for normally distributed and non-normally distributed continuous variables, respectively. Chi-square test or Fisher's exact test were used for comparisons of categorical data. To determine the severe bleeding risk factors of severe DVI, multivariate logistic regression analysis was performed. Stata version 14.1 was used for statistical analysis.
R E S U L T S
Risk factors of severe bleeding in severe DVI Of the 238 patients who had severe DVI, 44 (18.5%) had severe bleeding. The most common organs having severe bleeding were the GI tract, lower respiratory tract and urinary tract.
To determine the risk factors of severe bleeding, we compared the possible risk factors between the severe DVI patients with and without severe bleeding. DVI patients who had severe bleeding had significantly higher WSDS, a higher proportion of DHF grade IV, INR !1.5 and abnormal laboratory findings including lower levels of lowest hematocrit and albumin and higher levels of highest white blood cells (WBCs), DB, TB, AST, ALT, blood urea nitrogen (BUN) and Cr; PT and aPTT were also more prolonged than in those without severe bleeding (Table 1 ).
Multivariate analysis found that patients who had DHF grade IV, platelets <20 000/mm 3 and INR ! 1.5 had an increased risk of severe bleeding with odds ratios [95% confidence interval (CI)] of 3.4 (1.4, 8.6), 2.6 (1.1, 6.2) and 10.6 (4.0, 28.4), respectively ( Table 2 ).
The outcome of severe DVI patients who had severe bleeding Among the 44 patients who had severe bleeding, there was a higher proportion of patients with organ failure, including ARF, ALF and AKI, than in those without severe bleeding, and 28 (63.6%) died ( Table 3 ). The median (IQR) durations of hospitalization in those who died and survived were 7 (3, 14) days and 4 (3, 6) days, respectively.
Patients with and without fatal severe bleeding had at least two organs bleeding in 12 of 28 (42.9%) and 1 of 16 (6.2%) patients, respectively. In the 12 fatal severe bleeding patients who had at least two organs bleeding, three patients had three organs involved (all with GI and lower respiratory tract bleeding, two with urinary tract bleeding and one with intracranial hemorrhage) and nine patients had two organs involved (all with GI bleeding; four and five with lower respiratory tract and urinary tract bleeding, respectively).
Lower respiratory tract bleeding was found only in patients who had ARF, and 12 of 14 of these patients died. Of the 23 available urine examinations in patients with severe bleeding, gross hematuria was found in eight patients who also had AKI, and seven of these eight patients died. Table 4) .
The proportion of patients who had INR ! 1.5 was significantly higher in patients who had profound shock (57.1% vs. 1.2%), multiorgan failure (87.5% vs. 5.0%) and died (96.6% vs. 15.8%) (all p < 0.01), compared with those who did not have profound shock, had no or one organ failure and survived, respectively.
D I S C U S S I O N
Severe DVI children who had profound shock, platelets < 20 000/mm 3 and/or INR !1.5 were at high risk of having severe bleeding with a high mortality rate of 63.6%. INR had a high correlation with LFTs abnormalities.
PT is affected by factor VII levels, the shortest half-life (3-4 h) coagulation factors, which are synthesized by the liver. We found that INR ! 1.5 was the most important risk factor of severe bleeding and INR had high correlations with DB, TB, AST and ALT levels. Previous studies have found that DVIrelated bleeding disorder patients had higher AST and ALT levels [13-16, 18, 26] than those who had no bleeding. Taking these various factors together suggests that acute liver injury plays the key role in hemorrhage in DVI patients by decreased synthesis and increased consumption of coagulation factors, which then subsequently causes prolonged PT and aPTT [10, 19, 30] .
However, other studies have found that the proportions of patients who had PT prolongation were not significantly different (4.4% vs. 0.5%) between those who had and did not have hemorrhage [16] and that PT prolongation had only a weak correlation with transaminase levels [18] . We found a significantly higher proportion of PT prolongation in patients with severe bleeding (90.5% vs. 23.4%). The reason for these different findings could be that in our study we enrolled only severe DVI patients, and the definition of DVI-related bleeding disorder in our study involved more severe bleeding than in the others. In addition, our study enrolled only children aged <15 years, while the others enrolled adult patients, and so, confounding factors such as underlying disease might have affected the other results. Our findings were supported by Chua et al., who found that children hospitalized with DHF/DSS who had normal PT levels had a low rate of severe bleeding; our study had a negative predictive value of 89%, and the Chua et al. study had a comparably high 71% [20] . Most coagulation factors are synthesized by the liver; we found that aPTT prolongation had a Factors included in the model were grade of DHF (DHF grade IV vs. DHF grades I-III), age ( 5 vs. >5 years), obesity (WSDS > 2 vs. WSDS 2), platelet count (<20 000/mm 3 vs. !20,000/mm [18] . In multivariate analysis, PT, but not aPTT, was the major risk factor for severe bleeding. This finding can be explained by noting that Factor VII has the shortest half-life of the coagulation factors, and thus can be affected more easily than the other coagulation factors.
The moderate correlations between coagulograms (PT, aPTT) and WBCs in our study could be explained by noting that patients with severe bleeding had high levels of inflammatory cytokines and stress hormones, both of which induce leukocytosis [31, 32] .
We also found that platelet counts had weak negative correlations with DB, TB, AST and ALT, a finding similar to a previous study [18] . Platelet counts also had weak negative correlations with PT and aPTT. In addition, platelet counts, PT and aPTT also had weak correlations with albumin levels. The weak correlations among platelet counts, coagulograms and albumin levels could be explained by noting that there are many factors (severity of endothelium and hepatocyte cell injuries, ALF-caused DIC leading to consumptive coagulopathy and thrombocytopenia, etc.), which influence platelet counts, coagulograms and albumin levels in a similar manner [10, 11, 17] .
We found as in a previous study that the GI tract is the most common site of severe bleeding causing death [6] . This previous study found that all six of the six fatal cases who had massive GI bleeding had PT prolongation and two of six had platelets <20 000/mm 3 , [6] which was similar to our study in that the majority (90%) of patients who had severe bleeding had PT prolongation and half of them had platelets <20 000/mm 3 . We found that severe DVI children who had severe bleeding had a high mortality rate; even though aggressive treatment with blood components was provided, the severe bleeding could not be stopped in the majority of fatal cases. Of the three patients who received recombinant factor VII, all died from massive bleeding.
The one notable limitation in this retrospective study was that LFTs and coagulograms had not been performed in two of three of the patients without severe bleeding. In multivariate analysis, we found that patients who had no INR results had a low risk (odds ratio: 0.1, 95% CI: 0-0.1) of having severe bleeding. This finding suggests that the majority of these patients who had not had these tests had normal/minimal abnormalities in their coagulograms.
In conclusion, our retrospective study found that severe DVI children who had severe bleeding were more likely to have DHF grade IV, platelets <20 000/mm 3 and/or INR !1.5. Acute liver injury might play the key role in PT and aPTT prolongation through decreased synthesis and consumption of coagulation factors. Most fatal severe bleeding patients had uncontrolled bleeding and multi-organ failure.
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